MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study

Figure 3

The prognosis analysis of MYL5 expression in Kaplan–Meier plotter and PrognoScan datasets. Correlation between MYL5 expression and prognosis of various types of cancer in Kaplan–Meier (a–l) and PrognoScan datasets (m–t). OS: overall survival, PFS: progression-free survival, PPS: postprogression survival, FP: first progression, DRFS: distant recurrence free survival, DMFS: distant metastases-free survival, RFS: relapse-free survival, AML: acute myelocytic leukemia, and MM: multiple myeloma.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)

(s)

(t)